Esophagogastric Adenocarcinoma
About
Mappings
NCI Thesaurus: Gastroesophageal Junction Carcinoma (coding:ncit:C203675)
OncoTree: Esophagogastric Adenocarcinoma (coding:oncotree:EGC)
Therapeutic response
Precision oncology relationships for therapeutic response involving this cancer type.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| EMA (1) | HER2-positive | Esophagogastric Adenocarcinoma | Capecitabine, Cisplatin, Trastuzumab | |
| EMA (1) | HER2-positive | Esophagogastric Adenocarcinoma | Cisplatin, Fluorouracil, Trastuzumab | |
| EMA (1) | ERBB2 amplification | Esophagogastric Adenocarcinoma | Capecitabine, Cisplatin, Trastuzumab | |
| EMA (1) | ERBB2 amplification | Esophagogastric Adenocarcinoma | Cisplatin, Fluorouracil, Trastuzumab | |
| EMA (1) | MSI-H | Esophagogastric Adenocarcinoma | Pembrolizumab | |
| EMA (1) | dMMR | Esophagogastric Adenocarcinoma | Pembrolizumab |